Skadden advised China Merchants Securities (HK) Co., Limited as the sole sponsor, sole global coordinator, sole bookrunner and sole lead manager in the HK$320 million initial public offering of Sinco Pharmaceuticals Holdings Limited on the Hong Kong Stock Exchange.